<?xml version="1.0" encoding="UTF-8"?>
<TEI xmlns="http://www.tei-c.org/ns/1.0" xml:lang="en">
  <teiHeader>
    <fileDesc>
      <titleStmt>
        <title>Selective Silencing of Hippocampal Parvalbumin Interneurons Induces Development of Recurrent Spontaneous Limbic Seizures in Mice</title>
        <author>Drexel</author>
        <author>Romanov</author>
        <author>Wood</author>
        <author>Weger</author>
        <author>Heilbronn</author>
        <author>Wulff</author>
        <author>Tasan</author>
        <author>Harkany</author>
      </titleStmt>
      <publicationStmt>
        <p>Tag layer of the DHSS Meta-Tagging Project. The article text is reproduced from the
           staged copy named in sourceDesc and is not altered; the tags are held separately in
           standOff so that overlapping and nested spans are preserved.</p>
      </publicationStmt>
      <sourceDesc>
        <bibl>
          <title>Selective Silencing of Hippocampal Parvalbumin Interneurons Induces Development of Recurrent Spontaneous Limbic Seizures in Mice</title>
          <date>2017</date>
          <publisher>The Journal of Neuroscience</publisher>
          <idno type="DOI">10.1523/jneurosci.3456-16.2017</idno>
          
          <idno type="record">Drexel2017-selective-silencing-of-hippocampal-parvalbum</idno>
          <note type="staged-file">Drexel2017-selective-silencing-of-hippocampal-parvalbum.txt, the project's staged copy</note>
          <note type="text-sha1">9e173fad0a4d5b2936187beb94b6edb9b87670c7</note>
          <note type="rights">not-redistributable</note>
        </bibl>
      </sourceDesc>
    </fileDesc>
    <profileDesc>
      <textClass><keywords><term>neuroscience</term></keywords></textClass>
      <particDesc>
        <person xml:id="paper"><p>the paper's own words</p></person>
        <person xml:id="tagger"><p>the tag layer; a sentence written by the tagger about the
          paper, always anchored to a quotation but not itself a quotation</p></person>
      </particDesc>
    </profileDesc>
    <revisionDesc>
      <change when="2026-10-06"
              who="build_paper_edition.py">0 spans located by searching the stored text for the quote's exact words, allowing any whitespace between them</change>
    </revisionDesc>
  </teiHeader>
  <standOff>
    <spanGrp type="tags">
      <span xml:id="t0" type="object_of_study" ana="#object_of_study" resp="#paper">
        <label>whether losing GABA release from parvalbumin interneurons in the ventral subiculum is by itself enough to produce temporal lobe epilepsy</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t1" type="research_question" ana="#research_question" resp="#paper">
        <label>whether a correlation seen in patients and models - selective loss of these cells - is causal, and whether the effect needs the silencing to be permanent</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t2" type="contribution" ana="#contribution" resp="#paper">
        <label>permanent silencing produces spontaneous recurrent seizures with no neurodegeneration, while transient silencing of the same cells produces nothing unless an excitatory challenge is added</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t3" type="claim_type" ana="#claim_type" resp="#paper">
        <label>mechanism</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t4" type="phenomenon" ana="#phenomenon" resp="#paper">
        <label>temporal lobe epileptogenesis</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t5" type="method" ana="#method" resp="#paper">
        <label>electrophysiology</label>
        <term>electrophysiology</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t6" type="mechanisms" ana="#mechanisms[0]" resp="#tagger">
        <label>mechanisms</label>
        <term>sustained loss of perisomatic feedforward inhibition from parvalbumin basket cells lowers the seizure threshold of subicular pyramidal cells, which then generates spike-wave clusters and spontaneous seizures</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t7" type="mechanisms" ana="#mechanisms[1]" resp="#tagger">
        <label>mechanisms</label>
        <term>compensatory readaptation of the disturbed circuit (e.g. sprouting of inhibitory terminals) gradually damps the seizure rate after several weeks</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t8" type="mechanisms" ana="#mechanisms[2]" resp="#tagger" cert="1.0">
        <label>tetanus toxin light chain cleaves synaptobrevin, so GABA release is permanently gone from the transduced cells while the cells themselves survive</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t9" type="mechanisms" ana="#mechanisms[3]" resp="#tagger" cert="1.0">
        <label>and the resulting loss of perisomatic feedforward inhibition lowers the seizure threshold enough that a subconvulsive dose precipitates convulsions and then lasting epilepsy</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t10" type="mechanisms" ana="#mechanisms[4]" resp="#tagger" cert="1.0">
        <label>these cells are described as crucial during excitatory challenge and transiently dispensable under basal conditions, which is why a short silencing does nothing on its own</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t11" type="mechanisms" ana="#mechanisms[5]" resp="#tagger" cert="0.8">
        <label>with the later decline in seizure frequency attributed to unknown readaptation - inhibitory sprouting, reduced cannabinoid signaling, or compensation by untransduced cells</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t12" type="limitations" ana="#limitations[0]" resp="#tagger">
        <label>Vector expression was not confined to the subiculum, so silenced PV neurons elsewhere in the hippocampus may have contributed.</label>
        <note>what this limits: the attribution of the effect to subicular PV neurons: WE CANNOT EXCLUDE A CONTRIBUTION OF PV NEURONS SILENCED TO SOME EXTENT ALSO IN OTHER HIPPOCAMPAL SUBFIELDS</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t13" type="limitations" ana="#limitations[1]" resp="#tagger">
        <label>The absence of any change in overall evoked or miniature postsynaptic currents after silencing is unexplained.</label>
        <note>what this limits: the absence of change in evoked or miniature postsynaptic currents after silencing: THERE IS NO CLEAR EXPLANATION FOR THIS</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t14" type="limitations" ana="#limitations[2]" resp="#tagger">
        <label>Why seizure frequency declines after about five weeks is not known.</label>
        <note>what this limits: the decline in seizure frequency after about five weeks: THE UNDERLYING MECHANISMS ARE UNCLEAR</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t15" type="limitations" ana="#limitations[3]" resp="#tagger">
        <label>The seizure frequency the model produces is modest in absolute terms - roughly one to two per week - but still ABOVE the range most patients with temporal lobe epilepsy experience.</label>
        <note>what this limits: the model&#x27;s relevance to patients: THE FREQUENCY OF SRSs IS MODEST (APPROXIMATELY ONE TO TWO PER WEEK) BUT STILL BEYOND THE RANGE OF SEIZURE FREQUENCY IN MOST TLE PATIENTS · note: claim corrected 2026-08-20 by the project. The previous text read &#x27;The seizure frequency obtained is low relative to most patients with temporal lobe epilepsy.&#x27;, which REVERSES its own quote: the paper says the rate is modest &#x27;BUT STILL BEYOND the range of seizure frequency in most TLE…&#x27;. limitations[6], grounded on the same sentence, already read it correctly, and the disagreement between the two is what exposed it. The quote, the anchor and the scope are unchanged.</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t16" type="limitations" ana="#limitations[4]" resp="#tagger" cert="1.0">
        <label>the vector reached about 61% of parvalbumin cells and spilled beyond the subiculum, so a contribution from other subfields cannot be excluded</label>
        <note>what this limits: the anatomical specificity of the manipulation: THE INJECTIONS WERE NOT EXCLUSIVELY RESTRICTED TO THE SUBICULUM, BUT OFTEN ALSO AFFECTED SOME PV-CONTAINING INTERNEURONS IN SECTOR CA1 AND THE PRESUBICULUM AND PARASUBICULUM</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t17" type="limitations" ana="#limitations[5]" resp="#tagger" cert="1.0">
        <label>the standard synaptic measures showed nothing, and the paper says there is no clear explanation for that</label>
        <note>what this limits: the mechanistic account of the behavioural effect: DESPITE THE SIGNIFICANT EFFECTS OF VECTOR INJECTIONS ON THE BEHAVIOR OF THE ANIMALS, NEITHER OVERALL eIPSCs OR EVOKED EPSCs NOR mIPSCs OR mEPSCs WERE AFFECTED IN SUBICULAR PYRAMIDAL CELLS</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t18" type="limitations" ana="#limitations[6]" resp="#tagger" cert="1.0">
        <label>the seizure frequency the model produces is above what most patients with this epilepsy experience</label>
        <note>duplicate of: limitations[3] · what this limits: the same scope as limitations[3] - the seizure rate is above the clinical range</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t19" type="limitations" ana="#limitations[7]" resp="#tagger" cert="1.0">
        <label>the frequency of SRSs appeared to decline after several weeks, the underlying mechanisms are unclear, and one may consider a variety of mechanisms responsible for this</label>
        <note>what this limits: the time course of the effect: THE FREQUENCY OF SRSs APPEARED TO DECLINE AFTER SEVERAL WEEKS. THE UNDERLYING MECHANISMS ARE UNCLEAR</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t20" type="transfers" ana="#transfers[0]" resp="#tagger" cert="1.0">
        <label>a Cre-dependent viral construct carrying tetanus toxin light chain, used to make a silencing permanent rather than reversible</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t21" type="transfers" ana="#transfers[1]" resp="#tagger" cert="1.0">
        <label>the designer-receptor system, imported specifically to supply the SHORT time course the toxin cannot give</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t22" type="transfers" ana="#transfers[2]" resp="#tagger" cert="1.0">
        <label>a CB1 agonist used not as a treatment but as a subtraction, to remove one inhibitory source so the other becomes visible</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t23" type="transfers" ana="#transfers[3]" resp="#tagger" cert="1.0">
        <label>the observation that these cells are preferentially lost in patients, which is the correlation the whole experiment tries to convert into a cause</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t24" type="controls" ana="#controls[0]" resp="#tagger" cert="1.0">
        <label>a matched GFP vector injected the same way, monitored for the same 6 to 8 weeks</label>
        <note>eliminates: the injection of a vector as the cause - none of the AAV-GFP-injected mice exhibited C-SWDs or SRSs during the 6-8 week recording period · outcome: held</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t25" type="controls" ana="#controls[1]" resp="#tagger" cert="1.0">
        <label>the transient-silencing drug given together with a threshold dose of the convulsant, in a separate group</label>
        <note>eliminates: the reading that the transient manipulation simply failed to reduce GABA release - the null is a null about DURATION, not about whether anything happened · outcome (stated by the tagger, no quotation): held</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t26" type="controls" ana="#controls[2]" resp="#tagger" cert="1.0">
        <label>the same threshold-dose challenge given 10 days after injection, to mice with only a few discharges and no seizures</label>
        <note>eliminates: kindling by repeated discharges as the source of the lowered threshold, since the threshold is already down before the discharges accumulate · outcome (stated by the tagger, no quotation): held</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t27" type="controls" ana="#controls[3]" resp="#tagger" cert="1.0">
        <label>a cannabinoid agonist applied to suppress release from the OTHER basket cell population before measuring</label>
        <note>eliminates: the apparent absence of any synaptic effect - the manipulation is invisible until the competing inhibitory source is removed · outcome (stated by the tagger, no quotation): held</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t28" type="controls" ana="#controls[4]" resp="#tagger" cert="1.0">
        <label>double labeling of 2724 transduced neurons against GABA, parvalbumin and somatostatin in 25 mice</label>
        <note>eliminates: silencing of the wrong cell class as the explanation - though it also shows the classes overlap · outcome (stated by the tagger, no quotation): partial</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t29" type="controls" ana="#controls[5]" resp="#tagger" cert="0.9">
        <label>an activity marker counted across the hippocampal formation and neighbouring cortices</label>
        <note>eliminates: the possibility that the recorded events were local EEG artefacts rather than propagating seizures · outcome (stated by the tagger, no quotation): held</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t30" type="concepts" ana="#concepts[3]" resp="#paper">
        <label>GABA</label>
        <term>GABA</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t31" type="concepts" ana="#concepts[11]" resp="#paper">
        <label>transient</label>
        <term>transient</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t32" type="concepts" ana="#concepts[13]" resp="#paper">
        <label>threshold</label>
        <term>threshold</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t33" type="concepts" ana="#concepts[24]" resp="#paper">
        <label>CNO</label>
        <term>CNO</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t34" type="senses" ana="#senses[0]" resp="#tagger" cert="1.0">
        <label>THE DURATION OF THE MANIPULATION IS THE VARIABLE, NOT ITS TARGET: permanent silencing of these cells produces recurrent seizures, and TRANSIENT inhibition OF THE SAME CELLS IN THE SAME PLACE lowers the threshold but induces neither acute nor recurrent seizures</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t35" type="senses" ana="#senses[1]" resp="#tagger" cert="1.0">
        <label>stated again as the conclusion - ONLY SUSTAINED, BUT NOT TRANSIENT, inhibition of GABA release is capable of inducing seizures or epilepsy</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t36" type="senses" ana="#senses[2]" resp="#tagger" cert="1.0">
        <label>AND THE NULL IS A NULL ONLY WITHOUT A PROBE: transient inhibition combined with a threshold dose of the convulsant produced discharges and acute seizures within two hours - these cells are CRUCIAL PROTECTORS DURING EXCITATORY CHALLENGE while TRANSIENTLY DISPENSABLE UNDER BASAL CONDITIONS</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t37" type="senses" ana="#senses[3]" resp="#tagger" cert="1.0">
        <label>with the control that makes the null readable at all - a separate group shows the drug DID impair GABA release, so the absence of seizures is about duration and not about whether the manipulation worked</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t38" type="senses" ana="#senses[4]" resp="#tagger" cert="1.0">
        <label>THE STANDARD MEASURES ARE BLIND TO THE MANIPULATION AND THE PAPER SAYS SO: neither evoked nor miniature currents were affected despite the behavioral effect - THERE IS NO CLEAR EXPLANATION FOR THIS</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t39" type="senses" ana="#senses[5]" resp="#tagger" cert="1.0">
        <label>and the effect only appears once a competing source is pharmacologically removed - suppressing release from the OTHER basket cell population unmasks a reduction that the unsubtracted measure cannot see</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t40" type="senses" ana="#senses[6]" resp="#tagger" cert="1.0">
        <label>measured as a difference of two subtractions - 33% reduction in controls against 59% in treated animals, where the raw amplitudes did not differ at all</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t41" type="senses" ana="#senses[7]" resp="#tagger" cert="1.0">
        <label>A SELECTIVITY CLAIM WITH ITS OWN NUMBERS: 95.7% of transduced cells contained GABA, 83.2% parvalbumin and 23.7% somatostatin, from 2724 cells in 25 mice</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t42" type="senses" ana="#senses[8]" resp="#tagger" cert="1.0">
        <label>AND THE CATEGORIES OVERLAP, SO THE SELECTIVE MANIPULATION IS NOT SELECTIVE TO ONE FUNCTION: 15 to 30% of parvalbumin neurons ALSO contain somatostatin, and those cells - a different circuit motif - WERE THEREFORE ALSO AFFECTED</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t43" type="senses" ana="#senses[9]" resp="#tagger" cert="1.0">
        <label>with the anatomical leak declared too - the injections were not exclusively restricted to the target, and a contribution from other subfields CANNOT BE EXCLUDED</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t44" type="senses" ana="#senses[10]" resp="#tagger" cert="1.0">
        <label>and the coverage stated as a fraction rather than as success - 61.4% of parvalbumin interneurons at the injection site</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t45" type="senses" ana="#senses[11]" resp="#tagger" cert="1.0">
        <label>A LATENT STATE REVEALED BY A PROBE: mice with discharges but no seizures were already primed, and a threshold dose converted every one of them - and they then had recurrent seizures for the following two weeks</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t46" type="senses" ana="#senses[12]" resp="#tagger" cert="1.0">
        <label>AND A RIVAL EXPLANATION ELIMINATED BY MOVING THE PROBE EARLIER IN TIME: challenging at 10 days, before discharges could accumulate, shows the lowered threshold is not kindling by repeated discharges</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t47" type="senses" ana="#senses[13]" resp="#tagger" cert="1.0">
        <label>EPILEPSY WITHOUT CELL LOSS, WHICH IS WHAT MAKES IT A MODEL OF THE NONLESIONAL CASE: recurrent seizures develop NOTABLY WITHOUT SIGNS OF NEURODEGENERATION</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t48" type="senses" ana="#senses[14]" resp="#tagger" cert="1.0">
        <label>THE EFFECT FADES AND NOBODY KNOWS WHY: the seizure frequency declines after several weeks, THE UNDERLYING MECHANISMS ARE UNCLEAR, and five candidate mechanisms are listed with none tested</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t49" type="senses" ana="#senses[15]" resp="#tagger" cert="1.0">
        <label>and the model is declared out of range of the disease it models - the seizure frequency is BEYOND THE RANGE of most patients with this epilepsy</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t50" type="senses" ana="#senses[16]" resp="#tagger" cert="1.0">
        <label>AN INHIBITORY CELL CLASS THAT MAY BE EXCITATORY: axo-axonic cells, silenced along with the rest, MAY ALSO EXERT AN EXCITATORY FUNCTION through a locally reversed chloride gradient</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t51" type="senses" ana="#senses[17]" resp="#tagger" cert="1.0">
        <label>with the competing account of the same disease quoted in full - a deficit in DENDRITIC feedback inhibition lowers the threshold, while augmented SOMATIC feedforward inhibition limits epileptiform activity</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t52" type="alternatives" ana="#alternatives.claim_type" resp="#tagger">
        <label>claim_type: mechanism</label>
        <note>a second reading reaching the same value. Recorded: mechanism — note: a second reading reaching the same value from a different sentence. Not applied - a person decides.</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t53" type="alternatives" ana="#alternatives.method" resp="#tagger">
        <label>method: two silencing tools with different time courses applied to the same cells in the same place, so that duration is the manipulated variable</label>
        <note>a second reading DIFFERING from the recorded value. Recorded: electrophysiology — note: a second reading, verbatim-verified, disagreeing with the value on the record. Not applied - a person decides.</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t54" type="alternatives" ana="#alternatives.phenomenon" resp="#tagger">
        <label>phenomenon: temporal lobe epilepsy developing over a silent phase after an initial insult, with the mechanism of the transition poorly understood</label>
        <note>a second reading DIFFERING from the recorded value. Recorded: temporal lobe epileptogenesis — note: a second reading, verbatim-verified, disagreeing with the value on the record. Not applied - a person decides.</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t55" type="claim_relations" ana="#claim_relations[0]" resp="#tagger">
        <label>builds-on → Andrioli et al. (2007), Knopp et al. (2008) and Drexel et al. (2011), reporting selective loss of subicular PV interneurons in TLE patients and animal models</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t56" type="claim_relations" ana="#claim_relations[1]" resp="#tagger">
        <label>extends → Cammarota et al. (2013), Lee et al. (2014) and Toyoda et al. (2015) on the protective role of fast-spiking PV basket cells at seizure onset</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t57" type="claim_relations" ana="#claim_relations[2]" resp="#tagger">
        <label>replicates → Murray et al. (2011)</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t58" type="claim_relations" ana="#claim_relations[3]" resp="#tagger" cert="1.0">
        <label>supports → the causal role of parvalbumin interneuron loss in the subiculum in the development of temporal lobe epilepsy</label>
        <note>differs in: Quotation withheld</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t59" type="claim_relations" ana="#claim_relations[4]" resp="#tagger" cert="1.0">
        <label>qualifies → the reading that silencing these interneurons causes seizures - it does so only if the silencing is sustained</label>
        <note>differs in: only irreversible silencing of PV neurons by TeLC expression, but not a transient inhibition</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t60" type="claim_relations" ana="#claim_relations[5]" resp="#tagger" cert="1.0">
        <label>contradicts → the requirement that epilepsy in this model be accompanied by neurodegeneration</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t61" type="claim_relations" ana="#claim_relations[6]" resp="#tagger" cert="1.0">
        <label>distinguishes-from → kindling by accumulated discharges as the source of the lowered seizure threshold</label>
        <note>differs in: THE AXIS IS WHICH CAUSE PRODUCED THE THRESHOLD DROP. &#x27;Quotation withheld.&#x27; The manipulation and its own downstream consequence are confounded by design - the silencing produces the discharges, and the discharges could produce the threshold change - so the paper names the loop before testing it.</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t62" type="claim_relations" ana="#claim_relations[7]" resp="#tagger" cert="1.0">
        <label>critiques → its own synaptic measurements, which showed no effect and are left without a clear explanation</label>
        <note>differs in: THE AXIS IS WHICH LEVEL THE EFFECT APPEARS AT. &#x27;Despite the significant effects of vector injections on the behavior of the animals, neither overall eIPSCs or evoked EPSCs nor mIPSCs or mEPSCs were affected in subicular pyramidal cells ... This is rather surprising.&#x27; A behavioural effect with no matching synaptic effect, reported as unexplained - the paper declines to reconcile its own two levels and says so.</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t63" type="claim_relations" ana="#claim_relations[8]" resp="#tagger" cert="0.9">
        <label>supports → the account in which both dendritic and perisomatic inhibition matter, rather than one alone</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t64" type="concept_edges" ana="#concept_edges[0]" resp="#tagger" cert="1.0">
        <label>PV —causes→ GABA</label>
        <term>PV</term>
        <term>GABA</term>
        <note>strength of the relation: 1 · note: GABA release inhibited SELECTIVELY from PV neurons, permanently, by a viral tetanus toxin light chain
Audit 2026-09-28: DOUBTFUL - read against its full span and kept, but the study inhibited GABA RELEASE FROM PV neurons; &#x27;PV causes GABA&#x27; is loose.</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t65" type="concept_edges" ana="#concept_edges[3]" resp="#tagger" cert="1.0">
        <label>permanent —contrasted-with→ transient</label>
        <term>permanent</term>
        <term>transient</term>
        <note>strength of the relation: 1 · note: THE DURATION IS THE VARIABLE, NOT THE TARGET - transient inhibition of the SAME cells in the SAME place lowered the threshold but induced NEITHER acute NOR recurrent seizures</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t66" type="concept_edges" ana="#concept_edges[4]" resp="#tagger" cert="1.0">
        <label>transient —causes→ threshold</label>
        <term>transient</term>
        <term>threshold</term>
        <note>direction on the measure: reduces · strength of the relation: 1
Audit 2026-09-28: DOUBTFUL - read against its span and kept, but the span is cut before the threshold claim completes.</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t67" type="concept_edges" ana="#concept_edges[8]" resp="#tagger" cert="1.0">
        <label>TeLC —contrasted-with→ DREADD</label>
        <term>TeLC</term>
        <term>DREADD</term>
        <note>differs in: THE AXIS IS PERMANENCE OF THE SILENCING, WITH THE TRANSIENT DURATION GIVEN. &#x27;only irreversible silencing of PV neurons by TeLC expression, but not A TRANSIENT INHIBITION (FOR ~1 TO 2 H) through the DREADD system, results in C-SWDs or SRSs.&#x27; Both tools silence the same cells; the phenotype appears only for the irreversible one, so the result is about DURATION rather than about PV neurons - and a study using DREADDs would have found nothing and concluded differently. · strength of the relation: 1 · note: and the null turns positive with a probe - transient inhibition PLUS a threshold dose gave discharges and acute seizures, so these cells are CRUCIAL PROTECTORS DURING EXCITATORY CHALLENGE and TRANSIENTLY DISPENSABLE UNDER BASAL CONDITIONS</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t68" type="concept_edges" ana="#concept_edges[10]" resp="#tagger" cert="1.0">
        <label>CNO —causes→ GABA</label>
        <term>CNO</term>
        <term>GABA</term>
        <note>direction on the measure: reduces · strength of the relation: 1 · note: THE CONTROL THAT MAKES THE NULL READABLE - a separate group shows the drug DID impair GABA release, so the absence of seizures is about duration, not about whether anything happened</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t69" type="concept_edges" ana="#concept_edges[11]" resp="#tagger" cert="1.0">
        <label>PTZ —causes→ seizure</label>
        <term>PTZ</term>
        <term>seizure</term>
        <note>strength of the relation: 1
Audit 2026-09-28: DOUBTFUL - read against its span and kept, but PTZ is the convulsant challenge; the span shown is about verifying inhibition.</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t70" type="concept_edges" ana="#concept_edges[14]" resp="#tagger" cert="1.0">
        <label>basket cell —causes→ eIPSC</label>
        <term>basket cell</term>
        <term>eIPSC</term>
        <note>strength of the relation: 1 · note: the effect appears only once a COMPETING SOURCE is pharmacologically removed - suppressing release from the OTHER basket cell population unmasks a reduction the unsubtracted measure cannot see</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t71" type="concept_edges" ana="#concept_edges[16]" resp="#tagger" cert="1.0">
        <label>TeLC —causes→ eIPSC</label>
        <term>TeLC</term>
        <term>eIPSC</term>
        <note>strength of the relation: 1 · note: a difference of two subtractions - 33% reduction in controls against 59% in treated animals, where the raw amplitudes did not differ at all
Audit 2026-09-28: DOUBTFUL - read against its full span and kept, but TeLC-injected mice showed a larger WIN-induced eIPSC reduction (59% against 33%); causes is indirect and drops the comparison.</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t72" type="concept_edges" ana="#concept_edges[22]" resp="#tagger" cert="1.0">
        <label>TeLC —causes→ EEG</label>
        <term>TeLC</term>
        <term>EEG</term>
        <note>strength of the relation: 1 · note: 88% showed clustered discharges by day 16 and 64% at least one spontaneous seizure by day 28; NONE of the control-vector mice showed either
Audit 2026-09-28: DOUBTFUL - read against its full span and kept, but AAV-TeLC injection produced spike-wave discharges and seizures SEEN IN the EEG; &#x27;causes EEG&#x27; is loose.</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t73" type="concept_edges" ana="#concept_edges[23]" resp="#tagger" cert="1.0">
        <label>neurodegeneration —distinct-from→ epilepsy</label>
        <term>neurodegeneration</term>
        <term>epilepsy</term>
        <note>strength of the relation: 1 · note: EPILEPSY WITHOUT CELL LOSS, which is what makes it a model of the nonlesional case - NOTABLY WITHOUT SIGNS OF NEURODEGENERATION
Audit 2026-09-28: DOUBTFUL - read against its full span and kept, but epilepsy was induced &#x27;notably WITHOUT signs of neurodegeneration&#x27;; distinct-from is loose.</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t74" type="concept_edges" ana="#concept_edges[24]" resp="#tagger" cert="1.0">
        <label>permanent —causes→ seizure</label>
        <term>permanent</term>
        <term>seizure</term>
        <note>strength of the relation: 1
Audit 2026-09-28: DOUBTFUL - read against its span and kept, but the span says restricted inhibition induces recurrent discharges progressing to seizures; &#x27;permanent&#x27; is a fragment endpoint.</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t75" type="concept_edges" ana="#concept_edges[25]" resp="#tagger" cert="1.0">
        <label>threshold —operationalised-as→ PTZ</label>
        <term>threshold</term>
        <term>PTZ</term>
        <note>strength of the relation: 1 · note: A LATENT STATE REVEALED BY A PROBE - a threshold dose converted every primed mouse, and they then had recurrent seizures for the following two weeks
Audit 2026-09-28: DOUBTFUL - read against its span and kept, but PTZ was used to test seizure threshold; operationalised-as is loose.</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t76" type="concept_edges" ana="#concept_edges[35]" resp="#tagger" cert="1.0">
        <label>basket cell —causes→ pyramidal</label>
        <term>basket cell</term>
        <term>pyramidal</term>
        <note>strength of the relation: 1
Audit 2026-09-28: DOUBTFUL - read against its span and kept, but the span says basket cells exert feedforward inhibition on pyramidal cells; causes &#x27;pyramidal&#x27; drops &#x27;inhibition&#x27;.</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t77" type="concept_edges" ana="#concept_edges[36]" resp="#tagger" cert="1.0">
        <label>PV —part-of→ subiculum</label>
        <term>PV</term>
        <term>subiculum</term>
        <note>strength of the relation: 1 · note: the correlation the experiment tries to convert into a cause - PV interneurons preferentially lost in the subiculum of patients EVEN WITHOUT sclerosis
Audit 2026-09-28: DOUBTFUL - read against its span and kept, but the span says PV interneurons are lost in the subiculum; part-of is loose.</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t78" type="concept_edges" ana="#concept_edges[43]" resp="#tagger" cert="1.0">
        <label>pyramidal —part-of→ subiculum</label>
        <term>pyramidal</term>
        <term>subiculum</term>
        <note>strength of the relation: 1
Audit 2026-09-28: DOUBTFUL - read against its span and kept, but pyramidal neurons of the subiculum; part-of is loose.</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t79" type="content_tags" ana="#content_tags.statistics[0]" resp="#tagger">
        <label>Fisher&#x27;s exact test</label>
        <term>Fisher&#x27;s exact test</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t80" type="content_tags" ana="#content_tags.statistics[1]" resp="#tagger">
        <label>Kruskal-Wallis test</label>
        <term>Kruskal-Wallis test</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t81" type="content_tags" ana="#content_tags.statistics[2]" resp="#tagger">
        <label>ANOVA</label>
        <term>ANOVA</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t82" type="content_tags" ana="#content_tags.statistics[3]" resp="#tagger">
        <label>t-test</label>
        <term>t-test</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t83" type="content_tags" ana="#content_tags.statistics[4]" resp="#tagger">
        <label>statistical-significance</label>
        <term>statistical-significance</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t84" type="content_tags" ana="#content_tags.statistics[5]" resp="#tagger">
        <label>standard error of the mean</label>
        <term>standard error of the mean</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t85" type="content_tags" ana="#content_tags.statistics[6]" resp="#tagger" cert="0.9">
        <label>Two-way repeated-measures ANOVA</label>
        <term>Two-way repeated-measures ANOVA</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t86" type="content_tags" ana="#content_tags.statistics[7]" resp="#tagger" cert="0.8">
        <label>Kruskal–Wallis test</label>
        <term>Kruskal–Wallis test</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t87" type="content_tags" ana="#content_tags.findings[0]" resp="#tagger">
        <label>eighty-eight percent of the mice presented clusters of spike-wave discharges (C-SWDs) and 64% showed spontaneous recurrent seizures (SRSs)</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t88" type="content_tags" ana="#content_tags.findings[1]" resp="#tagger">
        <label>The epilepsy developed without any detectable loss of parvalbumin or GABA neurons, i.e. without neurodegeneration.</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t89" type="content_tags" ana="#content_tags.findings[2]" resp="#tagger">
        <label>Transient chemogenetic silencing of PV neurons for 1-2 h induced no discharge clusters or seizures over the following 5 days.</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t90" type="content_tags" ana="#content_tags.findings[3]" resp="#tagger">
        <label>Inhibiting GABA release from subicular/CA1 PV interneurons is by itself sufficient to lower the seizure threshold.</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t91" type="content_tags" ana="#content_tags.findings[4]" resp="#tagger">
        <label>The manipulation selectively cut the parvalbumin-mediated component of inhibition onto subicular pyramidal cells while leaving cholecystokinin-basket-cell inhibition intact.</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t92" type="content_tags" ana="#content_tags.findings[5]" resp="#tagger">
        <label>Seizure frequency did not grow indefinitely but fell back after about five weeks.</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t93" type="content_tags" ana="#content_tags.findings[6]" resp="#tagger">
        <label>A PTZ dose provoked acute tonic-clonic seizures in all TeLC-injected mice but in only one of seven GFP controls and none of five wild-type mice.</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t94" type="content_tags" ana="#content_tags.findings[7]" resp="#tagger" cert="1.0">
        <label>THE DURATION OF THE MANIPULATION IS THE VARIABLE, NOT ITS TARGET: transient inhibition of the SAME cells in the SAME place lowered the seizure threshold but induced NEITHER acute NOR recurrent seizures</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t95" type="content_tags" ana="#content_tags.findings[8]" resp="#tagger" cert="1.0">
        <label>ONLY SUSTAINED, BUT NOT TRANSIENT, inhibition of GABA release from these neurons is capable of inducing seizures or epilepsy</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t96" type="content_tags" ana="#content_tags.findings[9]" resp="#tagger" cert="1.0">
        <label>AND THE NULL IS A NULL ONLY WITHOUT A PROBE: transient inhibition plus a threshold dose gave discharges and acute seizures - these cells are crucial protectors during excitatory challenge and TRANSIENTLY DISPENSABLE under basal conditions</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t97" type="content_tags" ana="#content_tags.findings[10]" resp="#tagger" cert="1.0">
        <label>with the control that makes the null readable - a separate group shows the drug DID impair GABA release</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t98" type="content_tags" ana="#content_tags.findings[11]" resp="#tagger" cert="1.0">
        <label>THE STANDARD MEASURES ARE BLIND TO THE MANIPULATION: neither evoked nor miniature currents were affected despite the behavioral effect, and THERE IS NO CLEAR EXPLANATION FOR THIS</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t99" type="content_tags" ana="#content_tags.findings[12]" resp="#tagger" cert="1.0">
        <label>and the effect appears only once a competing source is pharmacologically removed</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t100" type="content_tags" ana="#content_tags.findings[13]" resp="#tagger" cert="1.0">
        <label>measured as a difference of two subtractions - 33% reduction in controls against 59% in treated animals</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t101" type="content_tags" ana="#content_tags.findings[14]" resp="#tagger" cert="1.0">
        <label>A SELECTIVITY CLAIM WITH ITS OWN NUMBERS: 95.7% of transduced cells contained GABA, 83.2% parvalbumin and 23.7% somatostatin, from 2724 cells in 25 mice</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t102" type="content_tags" ana="#content_tags.findings[15]" resp="#tagger" cert="1.0">
        <label>AND THE CATEGORIES OVERLAP: 15 to 30% of parvalbumin neurons also contain somatostatin, and those cells WERE THEREFORE ALSO AFFECTED</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t103" type="content_tags" ana="#content_tags.findings[16]" resp="#tagger" cert="1.0">
        <label>with the anatomical leak declared - the injections were not exclusively restricted to the target and a contribution from other subfields CANNOT BE EXCLUDED</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t104" type="content_tags" ana="#content_tags.findings[17]" resp="#tagger" cert="1.0">
        <label>and the coverage stated as a fraction rather than as success - 61.4% of parvalbumin interneurons at the injection site</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t105" type="content_tags" ana="#content_tags.findings[18]" resp="#tagger" cert="1.0">
        <label>22 of the 25 mice (88%) exhibited unprovoked C-SWDs, and NONE of the AAV-GFP-injected mice exhibited C-SWDs or SRSs during the 6-8 week recording period</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t106" type="content_tags" ana="#content_tags.findings[19]" resp="#tagger" cert="1.0">
        <label>EPILEPSY WITHOUT CELL LOSS: recurrent seizures develop NOTABLY WITHOUT SIGNS OF NEURODEGENERATION, which is what makes it a model of the nonlesional case</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t107" type="content_tags" ana="#content_tags.findings[20]" resp="#tagger" cert="1.0">
        <label>A LATENT STATE REVEALED BY A PROBE: mice with discharges but no seizures were already primed, and a threshold dose converted every one of them</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t108" type="content_tags" ana="#content_tags.findings[21]" resp="#tagger" cert="1.0">
        <label>AND A RIVAL ELIMINATED BY MOVING THE PROBE EARLIER IN TIME: challenging at 10 days shows the lowered threshold is not kindling by accumulated discharges</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t109" type="content_tags" ana="#content_tags.findings[22]" resp="#tagger" cert="1.0">
        <label>seizure frequency declined after several weeks, the mechanisms are unclear, and several candidate explanations are listed</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t110" type="content_tags" ana="#content_tags.findings[23]" resp="#tagger" cert="1.0">
        <label>and the model is declared out of range of the disease it models - the seizure frequency is BEYOND THE RANGE of most patients</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t111" type="content_tags" ana="#content_tags.findings[24]" resp="#tagger" cert="1.0">
        <label>axo-axonic cells may also exert an excitatory function through a locally reversed chloride gradient at their synapses</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t112" type="content_tags" ana="#content_tags.findings[25]" resp="#tagger" cert="1.0">
        <label>with the competing account quoted in full - a deficit in DENDRITIC feedback inhibition lowers the threshold while augmented SOMATIC feedforward inhibition limits epileptiform activity</label>
        <note>WHOSE RESULT THIS IS: Cossart et al. (2001) proposed - THE EVIDENCE FOR THIS ROW ATTRIBUTES THE WORK TO SOMEBODY ELSE. The cited name is the subject of a result verb and the sentence carries no first-person marker, so the finding, quantity or definition is the CITED author&#x27;s rather than this record&#x27;s. The claim is true and the quote is verbatim - what is wrong is whose result the corpus says it is. Nothing edited, nothing withdrawn: the row is marked so a page can name the source. Where the record is a commentary or review, its claim relations layer usually already names the paper being discussed - the record knows at one layer and forgets at another.</note>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t113" type="content_tags" ana="#content_tags.findings[26]" resp="#tagger" cert="1.0">
        <label>the transition from a normal to an epileptic brain takes years, and its cellular and molecular mechanisms are STILL POORLY UNDERSTOOD</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t114" type="content_tags" ana="#content_tags.findings[27]" resp="#tagger" cert="1.0">
        <label>ΔFosB was only barely expressed in controls and in mice that exhibited only C-SWDs, and prominently labeled neurons in the hippocampus, subiculum, and entorhinal and perirhinal cortices after frequent SRSs</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t115" type="content_tags" ana="#content_tags.findings[28]" resp="#tagger" cert="1.0">
        <label>with the human parallel stated - AS IN PATIENTS WITH NONLESIONAL TLE, these mice developed epilepsy without signs of neurodegeneration</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t116" type="content_tags" ana="#content_tags.findings[29]" resp="#tagger" cert="1.0">
        <label>and activating EITHER dendritic or perisomatic inhibition suppressed epileptiform activity, with all GABA neurons together more effective than either</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t117" type="content_tags" ana="#content_tags.definitions[0]" resp="#tagger">
        <label>seizure</label>
        <term>seizure</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t118" type="content_tags" ana="#content_tags.definitions[1]" resp="#tagger">
        <label>C-SWDs</label>
        <term>C-SWDs</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t119" type="content_tags" ana="#content_tags.definitions[2]" resp="#tagger">
        <label>DREADD (designer receptors exclusively activated by designer drugs)</label>
        <term>DREADD (designer receptors exclusively activated by designer drugs)</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t120" type="content_tags" ana="#content_tags.definitions[3]" resp="#tagger">
        <label>tetanus toxin light chain</label>
        <term>tetanus toxin light chain</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t121" type="content_tags" ana="#content_tags.definitions[4]" resp="#tagger" cert="1.0">
        <label>TeLC</label>
        <term>TeLC</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t122" type="content_tags" ana="#content_tags.definitions[5]" resp="#tagger" cert="1.0">
        <label>DREADD</label>
        <term>DREADD</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t123" type="content_tags" ana="#content_tags.definitions[6]" resp="#tagger" cert="0.9">
        <label>feedforward</label>
        <term>feedforward</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t124" type="content_tags" ana="#content_tags.definitions[7]" resp="#tagger" cert="0.9">
        <label>threshold</label>
        <term>threshold</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t125" type="content_tags" ana="#content_tags.variables[3]" resp="#tagger">
        <label>seizure threshold</label>
        <term>seizure threshold</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t126" type="content_tags" ana="#content_tags.variables[5]" resp="#tagger">
        <label>GFP vector</label>
        <term>GFP vector</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t127" type="content_tags" ana="#content_tags.variables[6]" resp="#tagger" cert="1.0">
        <label>threshold</label>
        <term>threshold</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t128" type="content_tags" ana="#content_tags.variables[7]" resp="#tagger" cert="1.0">
        <label>frequency</label>
        <term>frequency</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t129" type="content_tags" ana="#content_tags.variables[8]" resp="#tagger" cert="1.0">
        <label>expression</label>
        <term>expression</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t130" type="content_tags" ana="#content_tags.variables[9]" resp="#tagger" cert="1.0">
        <label>transient</label>
        <term>transient</term>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t131" type="content_tags" ana="#content_tags.quantities[0]" resp="#tagger">
        <label>88% — proportion of vector-injected mice showing unprovoked clusters of spike-wave discharges by day 16</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t132" type="content_tags" ana="#content_tags.quantities[1]" resp="#tagger">
        <label>64% — proportion of TeLC-injected mice that went on to develop spontaneous recurrent seizures</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t133" type="content_tags" ana="#content_tags.quantities[2]" resp="#tagger">
        <label>61.4 ± 2.43% — fraction of parvalbumin interneurons at the injection site that expressed the silencing construct</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t134" type="content_tags" ana="#content_tags.quantities[3]" resp="#tagger">
        <label>89.5% — share of spontaneous seizures that were immediately preceded by a preictal discharge cluster</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t135" type="content_tags" ana="#content_tags.quantities[4]" resp="#tagger">
        <label>24.6 ± 0.62 s — average duration of a spontaneous recurrent seizure</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t136" type="content_tags" ana="#content_tags.quantities[5]" resp="#tagger">
        <label>40.0 ± 9.07 per month/mouse — rate of discharge clusters per mouse per month</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t137" type="content_tags" ana="#content_tags.quantities[6]" resp="#tagger">
        <label>F (1,20) = 4.72, p = 0.0419 — group effect on the cannabinoid-insensitive (parvalbumin-mediated) component of the evoked IPSC</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t138" type="content_tags" ana="#content_tags.quantities[7]" resp="#tagger">
        <label>33% / 59% — reduction of evoked IPSC amplitude by the CB1 agonist in control versus silenced mice</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t139" type="content_tags" ana="#content_tags.quantities[8]" resp="#tagger">
        <label>∼73% — share of mice in which discharge clusters progressed to spontaneous recurrent seizures</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t140" type="content_tags" ana="#content_tags.quantities[9]" resp="#tagger">
        <label>p = 0.0047 — significance of the difference in acute pentylenetetrazole-induced convulsions between silenced mice and controls</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t141" type="content_tags" ana="#content_tags.quantities[10]" resp="#tagger" cert="1.0">
        <label>61.4 ± 2.43% — of the target cells actually reached by the vector - the manipulation&#x27;s coverage stated as a fraction, so &#x27;selective silencing&#x27; in the title means silencing three cells in five</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t142" type="content_tags" ana="#content_tags.quantities[11]" resp="#tagger" cert="1.0">
        <label>95.7 ± 0.68%, 83.2 ± 1.27%, and 23.7 ± 1.61% — of transduced cells containing GABA, parvalbumin and somatostatin - the third number is the one that shows the target category is not one functional class</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t143" type="content_tags" ana="#content_tags.quantities[12]" resp="#tagger" cert="1.0">
        <label>15–30% — of parvalbumin neurons that also contain somatostatin, so a manipulation aimed at one circuit motif necessarily hits another</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t144" type="content_tags" ana="#content_tags.quantities[13]" resp="#tagger" cert="1.0">
        <label>33% ... 59% — the reduction in the amplitude of eIPSCs by WIN 55,212-2 in AAV-GFP-injected mice and in mice injected with AAV-TeLC</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
      <span xml:id="t145" type="content_tags" ana="#content_tags.quantities[14]" resp="#tagger" cert="1.0">
        <label>one to two per week — the seizure frequency the model produces, stated as being ABOVE what most patients experience - a model&#x27;s severity reported against its target rather than on its own</label>
        <note type="quotation-withheld">Quotation withheld because this record is not cleared for redistribution.</note>
      </span>
    </spanGrp>
  </standOff>
  <text>
    <body>
      <p><note type="rights">The full text of this article is not redistributable, so it is
      not included here. The evidence sentences are withheld with it; the tag layer and its
      grounding status remain. The article itself is at https://doi.org/10.1523/jneurosci.3456-16.2017.</note></p>
    </body>
  </text>
</TEI>
